data_2jq0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jq0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.718 0.294 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.72 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.72 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 . . . . . 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.689 0.281 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 5.1 t-80 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.705 0.288 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.714 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 . . . . . 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.736 0.303 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.519 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.716 ' H ' HG21 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 2.2 t-20 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.693 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.693 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 9' ' ' ILE . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.498 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.712 HG21 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.712 ' H ' HG21 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.68 0.276 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.7 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.838 0.351 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 . . . . . 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 3' ' ' SER . 3.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.98 -5.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.363 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 1' ' ' PHE . 10.0 m -70.94 48.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.7 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.45 -33.77 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 -73.5 -21.04 60.52 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.9 t-20 56.04 111.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.034 -1.666 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' SER . 10.0 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.88 91.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.273 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 t 168.17 5.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.535 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp -113.02 -30.14 7.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.715 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.72 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.72 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 -49.58 -46.69 49.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -93.02 -129.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.024 -1.672 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.539 ' C ' ' H ' ' A' ' 3' ' ' SER . 11.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 73.99 -21.67 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.417 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 1' ' ' PHE . 18.0 p -74.25 44.63 0.2 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.571 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 2' ' ' LEU . 58.6 tp -124.41 -32.71 3.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.38 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 5.1 t-80 -44.94 -37.9 4.29 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -134.56 -71.42 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.009 -1.682 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 98.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t 175.89 -2.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.2 -18.15 13.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.714 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 -49.09 -40.98 34.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -55.33 -61.88 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.386 0 O-C-N 120.046 -1.659 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.61 -16.31 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 t -71.58 50.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.2 -43.52 0.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.673 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.519 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.716 ' H ' HG21 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -44.29 -46.02 8.95 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.87 -2.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.362 0 O-C-N 119.974 -1.704 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -72.95 -9.71 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 t -68.26 63.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 2' ' ' LEU . 5.5 tp -133.42 -31.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 2.2 t-20 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.693 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.693 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 -86.4 -14.59 42.93 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -79.56 -47.85 14.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.419 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 120.018 -1.676 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.45 31.55 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.487 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 t -170.71 4.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -109.85 -23.78 11.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 9' ' ' ILE . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.498 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 -104.17 13.5 32.22 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.9 t-20 -164.27 -66.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.03 -1.669 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OG ' ' A' ' 3' ' ' SER . 0.8 OUTLIER -74.27 96.02 2.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 16.7 m -173.86 11.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.536 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 tt -92.47 -57.84 2.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.92 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.712 HG21 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.712 ' H ' HG21 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 -100.31 -0.02 39.24 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ILE . 1.9 p30 37.57 -114.76 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 O-C-N 120.076 -1.64 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.18 77.2 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.563 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t 175.93 -0.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.505 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mt -110.53 -24.57 10.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.535 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.7 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 -44.92 -35.11 2.68 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' ALA . 9.6 t30 -145.1 172.25 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.643 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.403 0 O-C-N 120.056 -1.652 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.516 ' C ' ' H ' ' A' ' 3' ' ' SER . 43.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.85 22.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.461 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 1' ' ' PHE . 51.5 p -70.2 59.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -128.93 -29.41 2.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 -104.13 13.7 31.9 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 23.2 t-20 49.44 100.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.412 0 O-C-N 120.036 -1.665 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.456 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.739 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.739 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.718 0.294 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.722 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.722 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 . . . . . 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.689 0.281 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 12' ' ' VAL . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.8 t60 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.705 0.288 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.758 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.758 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 . . . . . 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 5.5 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.736 0.303 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.431 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.745 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 36.2 t30 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.744 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.74 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.74 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 4' ' ' LEU . 1.5 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.514 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.732 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.68 0.276 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.729 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.729 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.838 0.351 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 9' ' ' ILE . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.725 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.725 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 . . . . . 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 3' ' ' SER . 3.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.98 -5.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.363 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 1' ' ' PHE . 10.0 m -70.94 48.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.7 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -133.45 -33.77 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.739 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.739 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 -73.5 -21.04 60.52 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 18' ' ' HIS . 44.9 t30 56.04 111.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.034 -1.666 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' SER . 10.0 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.88 91.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.273 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 t 168.17 5.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.535 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' SER . 11.7 tp -113.02 -30.14 7.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.715 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.722 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.722 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 -49.58 -46.69 49.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -93.02 -129.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.024 -1.672 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 3' ' ' SER . 11.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 2' ' ' LEU . 0.7 OUTLIER 73.99 -21.67 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.417 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 1' ' ' PHE . 18.0 p -74.25 44.63 0.2 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.571 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.6 tp -124.41 -32.71 3.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.38 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 12' ' ' VAL . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.8 t60 -44.94 -37.9 4.29 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -134.56 -71.42 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.009 -1.682 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 98.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.472 ' C ' HD22 ' A' ' 4' ' ' LEU . 2.8 t 175.89 -2.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 3' ' ' SER . 4.2 mm? -107.2 -18.15 13.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.597 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.758 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.758 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 -49.09 -40.98 34.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -55.33 -61.88 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.386 0 O-C-N 120.046 -1.659 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.61 -16.31 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 t -71.58 50.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 5.5 tp -133.2 -43.52 0.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.673 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.745 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -44.29 -46.02 8.95 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.87 -2.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.362 0 O-C-N 119.974 -1.704 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -72.95 -9.71 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 t -68.26 63.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 2' ' ' LEU . 5.5 tp -133.42 -31.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 36.2 t30 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.744 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 -86.4 -14.59 42.93 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -79.56 -47.85 14.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.419 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 120.018 -1.676 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.45 31.55 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.487 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.422 ' H ' ' H ' ' A' ' 4' ' ' LEU . 17.9 t -170.71 4.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.682 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' SER . 9.2 mp -109.85 -23.78 11.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.74 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.74 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 -104.17 13.5 32.22 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.9 t-20 -164.27 -66.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.03 -1.669 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.27 96.02 2.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -173.86 11.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.536 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 4' ' ' LEU . 1.5 tt -92.47 -57.84 2.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.92 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.514 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.732 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 -100.31 -0.02 39.24 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.0 p-10 37.57 -114.76 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . 0.4 ' N ' HD21 ' A' ' 19' ' ' ASN . . . . . . . . 0 C--N 1.305 -1.329 0 O-C-N 120.076 -1.64 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.4 mp -77.18 77.2 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.563 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 4' ' ' LEU . 2.9 t 175.93 -0.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.505 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 3' ' ' SER . 4.4 mt -110.53 -24.57 10.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.535 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.729 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.729 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 -44.92 -35.11 2.68 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' ALA . 9.6 t30 -145.1 172.25 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.643 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.403 0 O-C-N 120.056 -1.652 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 3' ' ' SER . 43.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.85 22.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.461 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 1' ' ' PHE . 51.5 p -70.2 59.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -128.93 -29.41 2.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 9' ' ' ILE . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.725 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.725 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 -104.13 13.7 31.9 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 23.2 t-20 49.44 100.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.412 0 O-C-N 120.036 -1.665 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.456 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.739 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.739 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.718 0.294 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.722 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.722 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 . . . . . 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.689 0.281 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 12' ' ' VAL . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 5.1 t-80 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.705 0.288 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.758 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.758 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 . . . . . 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 5.5 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.736 0.303 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.431 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.745 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 2.2 t-20 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.744 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.74 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.74 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 4' ' ' LEU . 1.5 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.514 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.732 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.68 0.276 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.729 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.729 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.838 0.351 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 9' ' ' ILE . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.725 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.725 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 . . . . . 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 3' ' ' SER . 3.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.98 -5.94 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.363 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 1' ' ' PHE . 10.0 m -70.94 48.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.7 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -133.45 -33.77 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.7 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 mt -76.62 -36.75 1.76 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.841 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 74.2 Cg_endo -86.78 -5.61 7.92 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 123.268 2.645 . . . . 0.0 112.199 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -84.69 -48.79 9.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.555 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.18 82.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.42 -17.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.18 -35.99 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.703 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.1 60.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 15' ' ' ILE . 96.9 t -65.37 -9.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 6.4 t -95.06 -21.2 18.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.42 -38.66 63.0 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.923 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.739 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -53.18 -63.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.739 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.98 -41.46 92.04 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.309 -1.768 . . . . 0.0 110.393 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.2 tttm -77.31 -32.2 55.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.828 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 t-160 -73.5 -21.04 60.52 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.488 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.9 t-20 56.04 111.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.034 -1.666 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 3' ' ' SER . 10.0 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.88 91.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.273 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 t 168.17 5.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.535 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' SER . 11.7 tp -113.02 -30.14 7.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.715 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.725 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 96.7 mt -82.11 -33.26 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.987 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.0 Cg_endo -86.79 -6.28 7.73 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.161 2.574 . . . . 0.0 112.037 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -89.26 -48.73 7.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.82 70.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.7 -18.5 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.36 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.32 -33.83 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.45 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 13' ' ' SER . . . -59.43 -12.64 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.693 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' ILE . 42.8 t -52.84 -9.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 11' ' ' ALA . 39.9 t -95.66 -25.55 16.08 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.647 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -72.2 -34.0 68.04 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.179 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.722 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -57.09 -63.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.722 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.84 -41.88 92.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.154 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' SER . 11.9 ttmm -75.15 -34.49 61.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 14' ' ' ALA . 8.0 t-80 -49.58 -46.69 49.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.297 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -93.02 -129.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.024 -1.672 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 3' ' ' SER . 11.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 2' ' ' LEU . 0.7 OUTLIER 73.99 -21.67 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.417 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 1' ' ' PHE . 18.0 p -74.25 44.63 0.2 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.571 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.6 tp -124.41 -32.71 3.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.38 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.695 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 mt -73.13 -38.08 4.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 22.2 Cg_exo -61.08 -20.27 67.0 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.038 2.492 . . . . 0.0 111.807 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.61 -44.04 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.434 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 110.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.4 mt -70.72 -13.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.637 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' C ' ' N ' ' A' ' 12' ' ' VAL . 5.4 t30 -91.84 -50.83 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.1 -20.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.687 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 12' ' ' VAL . 91.1 t -64.4 -8.99 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 7.7 t -95.61 -22.41 17.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.783 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.774 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.7 -33.08 62.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.761 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.08 -63.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.27 -39.95 92.3 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.309 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 ttmp? -79.25 -30.67 43.22 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.285 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.774 ' N ' ' O ' ' A' ' 14' ' ' ALA . 5.1 t-80 -44.94 -37.9 4.29 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -134.56 -71.42 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.009 -1.682 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 98.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.472 ' C ' HD22 ' A' ' 4' ' ' LEU . 2.8 t 175.89 -2.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 3' ' ' SER . 4.2 mm? -107.2 -18.15 13.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.597 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.694 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.0 mt -76.49 -36.66 1.79 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.937 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 72.4 Cg_endo -87.63 -6.7 6.8 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 123.377 2.718 . . . . 0.0 112.256 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.31 -52.56 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.0 74.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.003 0.43 . . . . 0.0 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -66.17 -16.07 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -83.36 -43.91 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.37 -17.41 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.63 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 15' ' ' ILE . 23.7 t -58.59 -8.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.677 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 17' ' ' LYS . 28.4 t -95.35 -23.81 17.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.752 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.8 -33.35 64.17 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.253 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.758 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.36 -62.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.758 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -59.46 -41.95 90.9 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.065 -1.88 . . . . 0.0 110.158 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tttp -75.16 -35.3 61.63 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.752 ' N ' ' O ' ' A' ' 14' ' ' ALA . 14.8 t-80 -49.09 -40.98 34.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.194 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -55.33 -61.88 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.386 0 O-C-N 120.046 -1.659 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.61 -16.31 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.1 t -71.58 50.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 5.5 tp -133.2 -43.52 0.86 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.673 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.698 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.1 mt -76.91 -36.98 1.69 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.919 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 32.2 Cg_exo -58.13 -20.08 44.49 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 123.087 2.525 . . . . 0.0 111.887 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 1.2 t-80 -76.22 -37.45 57.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.123 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.48 78.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.539 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' ILE . 96.7 mt -71.61 -15.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -79.4 -42.79 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -20.25 31.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.569 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 15' ' ' ILE . 54.0 t -71.46 -8.67 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.798 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 8.0 t -95.46 -22.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.717 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.27 -32.92 63.11 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.324 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.745 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.42 -62.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.745 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.85 -39.43 91.81 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.342 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 13' ' ' SER . 42.6 tttp -79.22 -30.97 43.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.768 ' N ' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -44.29 -46.02 8.95 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.87 -2.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.546 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.362 0 O-C-N 119.974 -1.704 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -72.95 -9.71 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.379 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 t -68.26 63.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 2' ' ' LEU . 5.5 tp -133.42 -31.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 mt -74.81 -37.38 2.7 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.523 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 33.6 Cg_exo -56.89 -17.16 22.77 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.074 2.516 . . . . 0.0 111.981 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -89.6 -43.19 10.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.561 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.78 -16.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.472 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 13' ' ' SER . 2.2 t-20 -93.87 -44.44 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.589 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -52.52 -16.37 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.689 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 15' ' ' ILE . 35.7 t -53.44 -9.81 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -95.64 -24.36 16.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.71 -37.09 65.26 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.287 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.744 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.38 -64.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 176.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.744 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.453 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 13' ' ' SER . 57.5 tttp -78.49 -31.16 47.62 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.323 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.823 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.2 t60 -86.4 -14.59 42.93 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.515 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -79.56 -47.85 14.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.419 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 120.018 -1.676 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.45 31.55 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.487 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.422 ' H ' ' H ' ' A' ' 4' ' ' LEU . 17.9 t -170.71 4.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.682 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' SER . 9.2 mp -109.85 -23.78 11.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.705 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.1 mm -76.38 -36.2 1.73 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.016 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 28.1 Cg_exo -58.69 -16.83 32.59 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.012 2.475 . . . . 0.0 111.972 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -87.65 -41.96 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.93 -34.45 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.52 -17.0 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -91.95 -31.74 15.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.513 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.06 -17.36 3.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 15' ' ' ILE . 88.0 t -60.43 -9.15 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 5.8 t -95.87 -23.05 17.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.632 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.772 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -74.51 -31.95 62.34 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.261 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.74 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.85 -64.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.74 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.25 -39.6 87.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.356 -1.747 . . . . 0.0 110.396 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 85.5 tttt -79.53 -30.89 42.0 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.181 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.772 ' N ' ' O ' ' A' ' 14' ' ' ALA . 6.7 t60 -104.17 13.5 32.22 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.762 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 15' ' ' ILE . 3.9 t-20 -164.27 -66.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.03 -1.669 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.27 96.02 2.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -173.86 11.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.536 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 4' ' ' LEU . 1.5 tt -92.47 -57.84 2.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.92 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.689 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.5 mt -72.4 -38.36 5.29 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 26.3 Cg_exo -59.46 -19.73 53.13 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 123.064 2.509 . . . . 0.0 111.749 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.514 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -81.98 -43.46 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.17 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.384 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 9' ' ' ILE . 79.3 mt -66.93 -14.99 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -92.3 -31.85 15.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.43 -20.0 51.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' ILE . 57.5 t -61.64 -8.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' LYS . 5.9 t -95.64 -23.13 17.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.64 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.91 -32.47 63.57 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.217 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.732 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.64 -62.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -62.45 -38.79 91.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.452 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 13' ' ' SER . 59.1 tttm -80.23 -30.72 38.59 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.258 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.765 ' N ' ' O ' ' A' ' 14' ' ' ALA . 34.5 t-80 -100.31 -0.02 39.24 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.701 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ILE . 1.9 p30 37.57 -114.76 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 O-C-N 120.076 -1.64 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.4 mp -77.18 77.2 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.563 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 4' ' ' LEU . 2.9 t 175.93 -0.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.505 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 3' ' ' SER . 4.4 mt -110.53 -24.57 10.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.535 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.5 mm -75.75 -36.63 2.05 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.746 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 27.3 Cg_exo -59.02 -19.28 47.57 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 123.002 2.468 . . . . 0.0 111.962 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.65 -43.56 14.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.23 86.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.386 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.9 mt -67.17 -18.08 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.337 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -89.86 -37.25 14.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.568 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' ILE . 92.8 t -57.99 -8.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.551 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 17' ' ' LYS . 11.1 t -95.64 -23.84 16.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.749 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.78 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -73.83 -33.01 63.96 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.167 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.729 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.35 -62.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.729 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -60.87 -40.6 93.56 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.248 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 13' ' ' SER . 34.1 tptt -78.7 -31.72 46.68 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.118 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.78 ' N ' ' O ' ' A' ' 14' ' ' ALA . 10.0 t-80 -44.92 -35.11 2.68 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' ALA . 9.6 t30 -145.1 172.25 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.643 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.403 0 O-C-N 120.056 -1.652 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 3' ' ' SER . 43.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.85 22.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.461 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 1' ' ' PHE . 51.5 p -70.2 59.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -128.93 -29.41 2.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.621 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.714 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 32.3 mm -82.64 -33.37 0.6 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.02 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 5' ' ' ILE . 62.9 Cg_endo -84.46 -10.93 8.51 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.069 2.513 . . . . 0.0 112.013 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 7' ' ' HIS . 0.5 OUTLIER -84.98 -46.89 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.41 78.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 9' ' ' ILE . 97.0 mt -66.35 -16.2 20.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.81 -31.68 19.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.23 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 t -61.21 -9.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.405 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 4.4 t -95.71 -21.44 18.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.624 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.784 ' O ' ' N ' ' A' ' 18' ' ' HIS . . . -75.13 -32.72 61.43 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.238 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.725 HG23 ' H ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -58.86 -62.61 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 176.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.725 ' H ' HG23 ' A' ' 15' ' ' ILE . . . -61.33 -40.06 92.81 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.433 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 13' ' ' SER . 63.4 tttp -79.59 -31.29 41.76 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.203 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.784 ' N ' ' O ' ' A' ' 14' ' ' ALA . 7.7 t60 -104.13 13.7 31.9 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 15' ' ' ILE . 23.2 t-20 49.44 100.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.412 0 O-C-N 120.036 -1.665 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_